Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Increased type-I interferon level is associated with liver damage and fibrosis in primary sclerosing cholangitis.
Salzmann RJS, Krötz C, Mocan T, Mocan LP, Grapa C, Rottmann S, Reichelt R, Keller CM, Langhans B, Schünemann F, Pohl A, Böhler T, Bersiner K, Krawczyk M, Milkiewicz P, Sparchez Z, Lammert F, Gehlert S, Gonzalez-Carmona MA, Willms A, Strassburg CP, Kornek MT, Dold L, Lukacs-Kornek V. Salzmann RJS, et al. Among authors: gonzalez carmona ma. Hepatol Commun. 2024 Feb 14;8(3):e0380. doi: 10.1097/HC9.0000000000000380. eCollection 2024 Mar 1. Hepatol Commun. 2024. PMID: 38358371 Free PMC article.
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison.
Mahn R, Glüer OA, Sadeghlar F, Möhring C, Zhou T, Anhalt T, Monin MB, Kania A, Glowka TR, Feldmann G, Brossart P, Kalff JC, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA. Mahn R, et al. Among authors: gonzalez carmona ma. J Hepatocell Carcinoma. 2024 Jan 13;11:81-94. doi: 10.2147/JHC.S432948. eCollection 2024. J Hepatocell Carcinoma. 2024. PMID: 38239279 Free PMC article.
Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients.
Monin MB, Baier LI, Gorny JG, Berger M, Zhou T, Mahn R, Sadeghlar F, Möhring C, Boesecke C, van Bremen K, Rockstroh JK, Strassburg CP, Eis-Hübinger AM, Schmid M, Gonzalez-Carmona MA. Monin MB, et al. Among authors: gonzalez carmona ma. Liver Cancer. 2023 May 10;12(4):339-355. doi: 10.1159/000529608. eCollection 2023 Sep. Liver Cancer. 2023. PMID: 37901199 Free PMC article.
Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.
Sadeghlar F, Seelemann J, Vogt A, Möhring C, Zhou T, Mahn R, Kornek M, Lukacs-Kornek V, Casares N, Lasarte JJ, Sarobe P, van Beekum C, Matthaei H, Manekeller S, Kalff J, Schmidt-Wolf IGH, Strassburg CP, Gonzalez-Carmona MA. Sadeghlar F, et al. Among authors: gonzalez carmona ma. Immunol Invest. 2023 Nov;52(8):966-984. doi: 10.1080/08820139.2023.2261980. Epub 2023 Nov 24. Immunol Invest. 2023. PMID: 37846958
Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.
Möhring C, Khan O, Zhou T, Sadeghlar F, Mahn R, Kaczmarek DJ, Dold L, Toma M, Marinova M, Glowka TR, Matthaei H, Manekeller S, Kalff JC, Strassburg CP, Weismüller TJ, Gonzalez-Carmona MA. Möhring C, et al. Among authors: gonzalez carmona ma. Front Oncol. 2023 Aug 29;13:1227036. doi: 10.3389/fonc.2023.1227036. eCollection 2023. Front Oncol. 2023. PMID: 37711210 Free PMC article.
Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation?
Hübner YR, Spuck N, Berger M, Schlabe S, Rieke GJ, Breitschwerdt S, van Bremen K, Strassburg CP, Gonzalez-Carmona MA, Wasmuth JC, Rockstroh JK, Boesecke C, Monin MB. Hübner YR, et al. Among authors: gonzalez carmona ma. Infection. 2023 Dec;51(6):1855-1861. doi: 10.1007/s15010-023-02081-0. Epub 2023 Aug 9. Infection. 2023. PMID: 37555885 Free PMC article. No abstract available.
Impaired immunogenicity after vaccination for SARS-CoV-2 in patients with gastrointestinal cancer: does tumor entity matter?
Monin MB, Gorny JG, Berger M, Baier LI, Zhou T, Mahn R, Sadeghlar F, Möhring C, Boesecke C, van Bremen K, Rieke GJ, Schlabe S, Breitschwerdt S, Marinova M, Schmidt-Wolf IGH, Strassburg CP, Eis-Hübinger AM, Gonzalez-Carmona MA. Monin MB, et al. Among authors: gonzalez carmona ma. J Gastrointest Oncol. 2023 Jun 30;14(3):1218-1234. doi: 10.21037/jgo-22-1065. Epub 2023 Jun 26. J Gastrointest Oncol. 2023. PMID: 37435197 Free PMC article.
72 results